Emi Nishimagi

470 total citations
13 papers, 360 citations indexed

About

Emi Nishimagi is a scholar working on Pathology and Forensic Medicine, Dermatology and Epidemiology. According to data from OpenAlex, Emi Nishimagi has authored 13 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 4 papers in Dermatology and 4 papers in Epidemiology. Recurrent topics in Emi Nishimagi's work include Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Dermatologic Treatments and Research (3 papers). Emi Nishimagi is often cited by papers focused on Systemic Sclerosis and Related Diseases (11 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Dermatologic Treatments and Research (3 papers). Emi Nishimagi collaborates with scholars based in Japan and Czechia. Emi Nishimagi's co-authors include Yasushi Kawaguchi, Masako Hara, Kae Takagi, Chikako Fukasawa, Masayoshi Harigai, Naoyuki Kamatani, Naoyuki Kamatani, Takashi Satoh, Masataka Kuwana and Akiko Tochimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of the Rheumatic Diseases and Modern Rheumatology.

In The Last Decade

Emi Nishimagi

13 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emi Nishimagi Japan	8	218	120	88	81	55	13	360
Claudia Bonino Italy	9	213 1.0×	85 0.7×	62 0.7×	54 0.7×	64 1.2×	10	330
Taiji Nakashima Japan	9	151 0.7×	102 0.8×	135 1.5×	74 0.9×	43 0.8×	13	433
Yuri Masui Japan	14	230 1.1×	131 1.1×	110 1.3×	119 1.5×	102 1.9×	30	452
Wioleta Marut Netherlands	13	187 0.9×	183 1.5×	107 1.2×	58 0.7×	54 1.0×	17	420
Anna Stochmal Poland	9	186 0.9×	73 0.6×	54 0.6×	88 1.1×	92 1.7×	22	309
Salvatore Lupoli Italy	8	200 0.9×	101 0.8×	45 0.5×	56 0.7×	40 0.7×	12	339
Catherine Alderdice Canada	5	259 1.2×	135 1.1×	57 0.6×	121 1.5×	94 1.7×	7	470
Jasper Broen Netherlands	6	247 1.1×	261 2.2×	52 0.6×	87 1.1×	80 1.5×	10	505
Sachiko Akimoto Japan	10	125 0.6×	61 0.5×	56 0.6×	52 0.6×	29 0.5×	29	287
Sheron C. Lear United States	10	82 0.4×	132 1.1×	131 1.5×	68 0.8×	120 2.2×	16	440

Countries citing papers authored by Emi Nishimagi

Since Specialization

Citations

This map shows the geographic impact of Emi Nishimagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Nishimagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Nishimagi more than expected).

Fields of papers citing papers by Emi Nishimagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Nishimagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Nishimagi. The network helps show where Emi Nishimagi may publish in the future.

Co-authorship network of co-authors of Emi Nishimagi

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Nishimagi. A scholar is included among the top collaborators of Emi Nishimagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Nishimagi. Emi Nishimagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Tochimoto, Akiko, Yasushi Kawaguchi, Masako Hara, et al.. (2011). Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up. Modern Rheumatology. 21(3). 296–301. 13 indexed citations

2.

Tochimoto, Akiko, Yasushi Kawaguchi, Masako Hara, et al.. (2011). Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up. Modern Rheumatology. 21(3). 296–301. 14 indexed citations

3.

Kawaguchi, Yasushi, Isao Matsumoto, Emi Nishimagi, et al.. (2008). Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Annals of the Rheumatic Diseases. 68(5). 710–714. 78 indexed citations

4.

Nishimagi, Emi, Akiko Tochimoto, Yasushi Kawaguchi, et al.. (2007). Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement.. PubMed. 34(10). 2050–5. 38 indexed citations

5.

Kawaguchi, Yasushi, Emi Nishimagi, Akiko Tochimoto, et al.. (2006). Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts. Proceedings of the National Academy of Sciences. 103(39). 14501–14506. 69 indexed citations

6.

Kawaguchi, Yasushi, Kae Takagi, Masako Hara, et al.. (2004). Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis & Rheumatism. 50(1). 216–226. 99 indexed citations

7.

Nishimagi, Emi, Yasushi Kawaguchi, Eiichi Tanaka, Masako Hara, & Naoyuki Kamatani. (2004). Classification of systemic sclerosis in the Japanese population based on rapid progression of skin thickening. Modern Rheumatology. 14(3). 216–21. 4 indexed citations

8.

Nishimagi, Emi, et al.. (2004). Myocardial dysfunction in a patient with adult-onset Still's disease (AOSD).. PubMed. 22(4). 506–7. 5 indexed citations

9.

Nishimagi, Emi, Yasushi Kawaguchi, Eiichi Tanaka, Masako Hara, & Naoyuki Kamatani. (2004). Classification of systemic sclerosis in the Japanese population based on rapid progression of skin thickening. Modern Rheumatology. 14(3). 216–221. 3 indexed citations

10.

Kawaguchi, Yasushi, Masayoshi Harigai, Masako Hara, et al.. (2002). Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.. PubMed. 29(9). 1877–83. 22 indexed citations

11.

Tochimoto, Akiko, Emi Nishimagi, Tsuyoshi Kobashigawa, et al.. (2001). [A case of recurrent hemophagocytic syndrome complicated with systemic sclerosis: relationship between disease activity and serum level of IL-18].. PubMed. 41(3). 659–64. 3 indexed citations

12.

Nishimagi, Emi, Yasushi Kawaguchi, Chihiro Terai, et al.. (2001). Progressive Interstitial Renal Fibrosis Due to Chinese Herbs in a Patient with Calcinosis Raynaud Esophageal Sclerodactyly Telangiectasia (CREST) Syndrome.. Internal Medicine. 40(10). 1059–1063. 10 indexed citations

13.

Matsumoto, Jun, et al.. (2000). [A case of Sjögren's syndrome and systemic sclerosis complicated with acute pancreatitis].. PubMed. 40(3). 620–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact